person · Reporting owner

Blust Ryan

Disclosed activity across 1 company

Tapewire entity: 76583
SEC CIK: 0001983133

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Trulieve Cannabis Corp.TRUL · Entity 4418	Interim CFO	August 12, 2025	August 13, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Trulieve Cannabis Corp.

Report date August 12, 2025 · Filed August 13, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Subordinate Voting SharesSEC Table I · non-derivative	Direct	77,038	Reported balance After 2025-08-12 transaction · row 1 1 source row Row 1 · 2025-08-12 · Grant · Acquired 46,922 · Balance 77,038 F1: Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. subordinate voting share. 50% of the RSUs will vest on December 1, 2026, and the remaining 50% of the RSUs will vest on December 1, 2027.

Filing footnotes · ownership attribution and instrument terms

F1: Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. subordinate voting share. 50% of the RSUs will vest on December 1, 2026, and the remaining 50% of the RSUs will vest on December 1, 2027.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
August 12, 2025 Filed Aug 13, 2025 20:29 UTC	Trulieve Cannabis Corp. TRUL · Entity 4418	GrantSubordinate Voting Shares	46,922	$0.00	$0.00	Disclosure SEC source: 0001835207-25-000023 · primary_doc.xml · nonDerivative · entry 1 Blust Ryan · CIK 0001983133 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,038 F1 · shares: Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. subordinate voting share. 50% of the RSUs will vest on December 1, 2026, and the remaining 50% of the RSUs will vest on December 1, 2027. Read SEC document
March 25, 2025 Filed Mar 28, 2025 22:08 UTC	Trulieve Cannabis Corp. TRUL · Entity 4418	GrantStock Option (Right to Buy) · Derivative	78,167	$0.00 Strike: $4.03	$0.00	Disclosure SEC source: 0001835207-25-000016 · primary_doc.xml · derivative · entry 1 Blust Ryan · CIK 0001983133 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,167 Underlying: Subordinate Voting Shares · 78,167 shares Expires 2032-03-25 F1 · derivative.exercise_date: The option becomes exercisable in three annual installments, with one-third vesting on December 1, 2025, one-third vesting on December 1, 2026, and one-third vesting on December 1, 2027. Read SEC document
December 29, 2023 Filed Jan 17, 2024 01:41 UTC	Trulieve Cannabis Corp. TRUL · Entity 4418	Tax withholdingSubordinate Voting Shares	1,777	$5.24	$9,311.48	Disclosure SEC source: 0001209191-24-001686 · doc4.xml · nonDerivative · entry 1 Blust Ryan · CIK 0001983133 · Former Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,161 F1 · shares: Represents shares withheld for payment of tax liability in connection with vesting of 50% of restricted stock units ("RSUs") on December 29, 2023, the grant of which RSUs to the reporting person were previously reported on Form 4. Read SEC document
July 25, 2023 Filed Jul 28, 2023 01:47 UTC	Trulieve Cannabis Corp. TRUL · Entity 4418	GrantStock Option (Right to Buy) · Derivative	56,442	$0.00 Strike: $6.52	$0.00	Disclosure SEC source: 0001209191-23-043601 · doc4.xml · derivative · entry 2 Blust Ryan · CIK 0001983133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,442 Underlying: Subordinate Voting Shares · 56,442 shares Expires 2030-07-24 F2 · derivative.exercise_date: The option becomes exercisable in three annual installments, with one-third vesting on December 1, 2023, one-third vesting on December 1, 2024, and one-third vesting on December 1, 2025. Read SEC document
July 25, 2023 Filed Jul 28, 2023 01:47 UTC	Trulieve Cannabis Corp. TRUL · Entity 4418	GrantSubordinate Voting Shares	25,364	$0.00	$0.00	Disclosure SEC source: 0001209191-23-043601 · doc4.xml · nonDerivative · entry 1 Blust Ryan · CIK 0001983133 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,938 F1 · kind: Represents a grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one Trulieve Cannabis Corp. subordinate voting share. 50% of the RSUs will vest on December 1, 2024, and the remaining 50% of the RSUs will vest on December 1, 2025. Read SEC document
July 25, 2023 Filed Jan 17, 2024 00:09 UTC Amendment	Trulieve Cannabis Corp. TRUL · Entity 4418	GrantStock Option (Right to Buy) · Derivative	56,442	$0.00 Strike: $3.99	$0.00	Disclosure SEC source: 0001209191-24-001670 · doc4a.xml · derivative · entry 1 Blust Ryan · CIK 0001983133 · Former Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,442 Underlying: Subordinate Voting Shares · 56,442 shares Expires 2030-07-24 F1 · derivative.exercise_price: The original Form 4 filed on July 27, 2023, is amended by this Form 4 amendment to correct column 2 (Conversion or Exercise Price of Derivative Security), which was incorrectly reported in the original filing due to a clerical error. F2 · derivative.exercise_date: The option becomes exercisable in three annual installments, with one-third vesting on December 1, 2023, one-third vesting on December 1, 2024, and one-third vesting on December 1, 2025. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.